LANTERN PHARMA INC (LTRN:NASDAQ)

$0.7433 -0.0694 (-8.5394%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed LANTERN PHARMA INC (LTRN:NASDAQ) News Sources

Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ...

20-08-2026

yahoo.com

Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript

21-08-2026

fool.com

New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST)

05-09-2026

yahoo.com

Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23

17-09-2026

yahoo.com

New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global

19-09-2026

yahoo.com

Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET

23-09-2026

yahoo.com

Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering

30-09-2026

yahoo.com

Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC

07-10-2026

yahoo.com

Lantern Pharma secures Taiwan clearances for Phase II NSCLC study

08-10-2026

clinicaltrialsarena.com

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026

08-10-2026

yahoo.com

LANTERN PHARMA INC (LTRN:NASDAQ) Sentiment Trend

0 25 50 75 100 91 75 79 85 68 91 20 69 59 84 20-08-2026 21-08-2026 05-09-2026 17-09-2026 19-09-2026 23-09-2026 30-09-2026 07-10-2026 08-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

LANTERN PHARMA INC (LTRN:NASDAQ) FAQs

toggle

What is the current price of LANTERN PHARMA INC (LTRN:NASDAQ)?

The current price of LANTERN PHARMA INC (LTRN:NASDAQ) is $0.7433.


toggle

LANTERN PHARMA INC (LTRN:NASDAQ) absolute price change since previous trading day?

The absolute price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is $-0.0694.


toggle

LANTERN PHARMA INC (LTRN:NASDAQ) percentage price change since previous trading day?

The percentage price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is -8.5394%.


toggle

What is the most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ)?

The most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for LANTERN PHARMA INC (LTRN:NASDAQ)?

The most recent sentiment for LANTERN PHARMA INC (LTRN:NASDAQ) is .


SEC-8K** Filing Available For LANTERN PHARMA INC (LTRN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.